Expansion Opportunity Pharmatech Associates is planning to increase headcount by 50 in 2027 to support a new facility producing raw materials for Novo Nordisk, signaling a growing capacity and potential demand for regulatory, quality, and manufacturing services to scale operations.

Strategic Alliance Recent collaboration with U.S. Pharmacopeia enhances continuous manufacturing expertise, creating a joint value proposition for drug sponsors facing supply chain pressures and drug shortages, presenting opportunities for broader consulting, training, and implementation services.

Regulatory Focus Deep specialization in navigating FDA and international regulations, quality systems, risk assessments, CAPAs, and training positions Pharmatech to offer end-to-end compliance programs to sponsors navigating complex product development and commercialization timelines.

Technical Breadth Expertise spans small molecules, cell & gene therapy, biologics and advanced manufacturing technologies, enabling cross-sell to diverse client portfolios including startups and multinationals seeking integrated development and manufacturing support.

Market Position As a USP subsidiary with global reach and a multidisciplinary team, Pharmatech can position itself as a premium, regulatory-forward consultancy for sponsors aiming to reduce time-to-market, risk, and downstream regulatory hurdles during product development and scaling.